The action of genetic modifiers in heart development is evident from the differences in penetrance and patterns of heart phenotypes in DS, in DS mouse models and when the Tbx5 null allele is bred onto different mouse genetic backgrounds. The gene discussed is TBX5; the disease is Dravet syndrome.